866-997-4948(US-Canada Toll Free)

Amyotrophic lateral sclerosis (ALS) - Epidemiology Forecast to 2025

Published By :

DelveInsight

Published Date : Sep 2017

Category :

Pharmaceutical

No. of Pages : 40 Pages

DelveInsight Amyotrophic lateral sclerosis (ALS) - Epidemiology Forecast To 2025 provides an overview of the epidemiology trends of Amyotrophic lateral sclerosis (ALS) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Amyotrophic lateral sclerosis (ALS) prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Amyotrophic lateral sclerosis (ALS). The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Scope of the Report
The Report includes the prevalent population and how will it change over the next eight years.
Prevalent or incident cases segmented by age and sex.
Coverage of key Amyotrophic lateral sclerosis (ALS) subpopulations and its prevalent or incident cases
The key differences in epidemiology patterns across the seven market segments

Key Coverage and Benefits
The report will help in developing business strategies by understanding the trends shaping and driving the global Amyotrophic lateral sclerosis (ALS) market.
Identifying prevalent patient populations as well as risk factors in the global Amyotrophic lateral sclerosis (ALS) market will help to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the best opportunities for Amyotrophic lateral sclerosis (ALS) therapeutics in each of the markets covered.
1. Report Introduction
2. Snapshot of Total Prevalent or Incident cases by 7 MM
3. Executive Summary
Key Findings
4. Amyotrophic lateral sclerosis (ALS) Overview
Amyotrophic lateral sclerosis (ALS) Definition
Pathophysiology
Symptoms
5. Etiology
6. Risk Factors Associated with Amyotrophic lateral sclerosis (ALS)
7. Disease Burden & Unmet Need in the Market
8. Epidemiology and Patient Populations
Key Findings
Key Sources used and Forecast Methodology
Prevalent Cases and Incident Cases-2015-2025
Prevalent & Incident Cases by Category-2015-2025
Age-Specific Prevalent/ Incident Cases of Amyotrophic lateral sclerosis (ALS)
Sex-Specific Prevalent/Incident Cases of Amyotrophic lateral sclerosis (ALS)
Disease Type Specific Prevalent/Incident Cases of Amyotrophic lateral sclerosis (ALS)
9. Prevalent & Incident Cases by 7 MM-2015-2025
Amyotrophic lateral sclerosis (ALS) Epidemiology of United States-2025
Amyotrophic lateral sclerosis (ALS) Epidemiology of United Kingdom-2025
Amyotrophic lateral sclerosis (ALS) Epidemiology of Germany-2025
Amyotrophic lateral sclerosis (ALS) Epidemiology of France-2025
Amyotrophic lateral sclerosis (ALS) Epidemiology of Spain-2025
Amyotrophic lateral sclerosis (ALS) Epidemiology of Italy-2025
Amyotrophic lateral sclerosis (ALS) Epidemiology of Japan-2025
10. Key Takeaways
11. Appendix
12. Report Methodology
13. Consulting Services




List of Table

Table 1: Clinical subtypes of Indication
Table 2: Risk Factors
Table 3: Prevalence cases (%) Region wise
Table 4: Sources used for forecasting the data
Table 5: Amyotrophic lateral sclerosis (ALS) Global Epidemiology, (2015-2025)
Table 6: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) (Ages =XX Years), US (2015-2025)
Table 7: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) By Sex (Males & Females), US (2015-2025)
Table 8: Prevalent Cases By Amyotrophic lateral sclerosis (ALS) Sub-population, US (2015-2025)
Table 9: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) (Ages =XX Years), United Kingdom (2015-2025)
Table 10: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) By Sex (Males & Females), United Kingdom (2015-2025)
Table 11: Prevalent Cases By Amyotrophic lateral sclerosis (ALS) Sub-population, United Kingdom (2015-2025)
Table 12: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) (Ages =XX Years), Germany (2015-2025)
Table 13: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) By Sex (Males & Females), Germany (2015-2025)
Table 14: Prevalent Cases By Amyotrophic lateral sclerosis (ALS) Sub-population, Germany (2015-2025)
Table 15: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) (Ages =XX Years), France (2015-2025)
Table 16: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) By Sex (Males & Females), France (2015-2025)
Table 17: Prevalent Cases By Amyotrophic lateral sclerosis (ALS) Sub-population, France (2015-2025)
Table 18: Prevalent Cases of Amyotrophic lateral sclerosis (ALS)(Ages =XX Years), Italy (2015-2025)
Table 19: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) By Sex (Males & Females), Italy (2015-2025)
Table 20: Prevalent Cases By Amyotrophic lateral sclerosis (ALS) Sub-population, Italy (2015-2025)
Table 21: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) (Ages =XX Years), Spain (2015-2025)
Table 22: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) By Sex (Males & Females), Spain (2015-2025)
Table 23: Prevalent Cases By Amyotrophic lateral sclerosis (ALS) Sub-population, Spain (2015-2025)
Table 24: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) (Ages =XX Years), Japan (2015-2025)
Table 25: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) By Sex (Males & Females), Japan (2015-2025)
Table 26: Prevalent Cases By Amyotrophic lateral sclerosis (ALS) Sub-population, Japan (2015-2025)

List of Chart

Figure 1: Prevalence cases (%) Region wise
Figure 2: Sources used for forecasting the data
Figure 3: Amyotrophic lateral sclerosis (ALS) Global Epidemiology, (2015-2025)
Figure 4: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) (Ages =XX Years), US (2015-2025)
Figure 5: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) By Sex (Males & Females), US (2015-2025)
Figure 6: Prevalent Cases By Amyotrophic lateral sclerosis (ALS) Sub-population, US (2015-2025)
Figure 7: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) (Ages =XX Years), United Kingdom (2015-2025)
Figure 8: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) By Sex (Males & Females), United Kingdom (2015-2025)
Figure 9: Prevalent Cases By Amyotrophic lateral sclerosis (ALS) Sub-population, United Kingdom (2015-2025)
Figure 10: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) (Ages =XX Years), Germany (2015-2025)
Figure 11: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) By Sex (Males & Females), Germany (2015-2025)
Figure 12: Prevalent Cases By Amyotrophic lateral sclerosis (ALS) Sub-population, Germany (2015-2025)
Figure 13: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) (Ages =XX Years), France (2015-2025)
Figure 14: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) By Sex (Males & Females), France (2015-2025)
Figure 15: Prevalent Cases By Amyotrophic lateral sclerosis (ALS) Sub-population, France (2015-2025)
Figure 16: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) (Ages =XX Years), Italy (2015-2025)
Figure 17: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) By Sex (Males & Females), Italy (2015-2025)
Figure 18: Prevalent Cases By Amyotrophic lateral sclerosis (ALS) Sub-population, Italy (2015-2025)
Figure 19: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) (Ages =XX Years), Spain (2015-2025)
Figure 20: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) By Sex (Males & Females), Spain (2015-2025)
Figure 21: Prevalent Cases By Amyotrophic lateral sclerosis (ALS) Sub-population, Spain (2015-2025)
Figure 22: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) (Ages =XX Years), Japan (2015-2025)
Figure 23: Prevalent Cases of Amyotrophic lateral sclerosis (ALS) By Sex (Males & Females), Japan (2015-2025)
Figure 24: Prevalent Cases By Amyotrophic lateral sclerosis (ALS) Sub-population, Japan (2015-2025)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *